150 related articles for article (PubMed ID: 36770773)
41. LDH-A promotes malignant behavior via activation of epithelial-to-mesenchymal transition in lung adenocarcinoma.
Hou XM; Yuan SQ; Zhao D; Liu XJ; Wu XA
Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509961
[TBL] [Abstract][Full Text] [Related]
42. Identification of LBX2 as a novel causal gene of lung adenocarcinoma.
Hu J; Bai Y; Zhang Q; Li M; Yin R; Xu L
Thorac Cancer; 2020 Aug; 11(8):2137-2145. PubMed ID: 32567804
[TBL] [Abstract][Full Text] [Related]
43. Cancer/testis antigen HEMGN correlated with immune infiltration serves as a prognostic biomarker in lung adenocarcinoma.
Jiang Y; Yu L; Hu Q; Kang Y; You J; Huang C; Xu X; Chen L
Mol Immunol; 2023 Jan; 153():226-237. PubMed ID: 36563642
[TBL] [Abstract][Full Text] [Related]
44. MRPL12 Acts as A Novel Prognostic Biomarker Involved in Immune Cell Infiltration and Tumor Progression of Lung Adenocarcinoma.
Hu Y; Liu Y; Ma C; Ai K
Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769082
[TBL] [Abstract][Full Text] [Related]
45. MicroRNA-147b promotes lung adenocarcinoma cell aggressiveness through negatively regulating microfibril-associated glycoprotein 4 (MFAP4) and affects prognosis of lung adenocarcinoma patients.
Feng YY; Liu CH; Xue Y; Chen YY; Wang YL; Wu XZ
Gene; 2020 Mar; 730():144316. PubMed ID: 31884109
[TBL] [Abstract][Full Text] [Related]
46. Pan-cancer analysis of UBE2T with a focus on prognostic and immunological roles in lung adenocarcinoma.
Cao K; Ling X; Jiang X; Ma J; Zhu J
Respir Res; 2022 Nov; 23(1):306. PubMed ID: 36357897
[TBL] [Abstract][Full Text] [Related]
47. AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma.
Zhang S; Lu Y; Qi L; Wang H; Wang Z; Cai Z
Biomed Res Int; 2020; 2020():8571932. PubMed ID: 32904605
[TBL] [Abstract][Full Text] [Related]
48. C1orf74 positively regulates the EGFR/AKT/mTORC1 signaling in lung adenocarcinoma cells.
Guo J; Li A; Guo R; He Q; Wu Y; Gou Y; Jin J; Huang G
PeerJ; 2022; 10():e13908. PubMed ID: 36032960
[TBL] [Abstract][Full Text] [Related]
49. H2A Histone Family Member Z (H2AFZ) Serves as a Prognostic Biomarker in Lung Adenocarcinoma: Bioinformatic Analysis and Experimental Validation.
Li Z; Hu M; Qiu J; Feng J; Zhang R; Wu H; Hu G; Ren J
Med Sci Monit; 2022 Jan; 28():e933447. PubMed ID: 35027526
[TBL] [Abstract][Full Text] [Related]
50. Improvement of ACK1-targeted therapy efficacy in lung adenocarcinoma using chloroquine or bafilomycin A1.
Zhu J; Cao K; Zhao M; Ma K; Jiang X; Bai Y; Ling X; Ma J
Mol Med; 2023 Jan; 29(1):6. PubMed ID: 36647009
[TBL] [Abstract][Full Text] [Related]
51. High Expression of
Chen Y; Zhou M; Gu X; Wang L; Wang C
Dis Markers; 2022; 2022():8789515. PubMed ID: 35855850
[TBL] [Abstract][Full Text] [Related]
52. High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma.
Jin CY; Du L; Nuerlan AH; Wang XL; Yang YW; Guo R
Aging (Albany NY); 2020 Dec; 13(3):3518-3535. PubMed ID: 33411689
[TBL] [Abstract][Full Text] [Related]
53. HMMR associates with immune infiltrates and acts as a prognostic biomaker in lung adenocarcinoma.
Ma X; Xie M; Xue Z; Yao J; Wang Y; Xue X; Wang J
Comput Biol Med; 2022 Dec; 151(Pt A):106213. PubMed ID: 36306573
[TBL] [Abstract][Full Text] [Related]
54. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.
Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H
Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503
[TBL] [Abstract][Full Text] [Related]
55. Upregulation of NDUFAF2 in Lung Adenocarcinoma Is a Novel Independent Prognostic Biomarker.
Zou K; Gao P; Xu X; Zhang W; Zeng Z
Comput Math Methods Med; 2023; 2023():2912968. PubMed ID: 36703939
[TBL] [Abstract][Full Text] [Related]
56. Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates.
Wei Q; Miao T; Zhang P; Jiang B; Yan H
Front Genet; 2022; 13():984575. PubMed ID: 36159963
[No Abstract] [Full Text] [Related]
57. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
58. Gene landscape and correlation between B-cell infiltration and programmed death ligand 1 expression in lung adenocarcinoma patients from The Cancer Genome Atlas data set.
Ho KH; Chang CJ; Huang TW; Shih CM; Liu AJ; Chen PH; Cheng KT; Chen KC
PLoS One; 2018; 13(12):e0208459. PubMed ID: 30521597
[TBL] [Abstract][Full Text] [Related]
59. ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma.
Zhang YH; Zeng J; Liu XS; Gao Y; Kui XY; Liu XY; Zhang Y; Pei ZJ
Front Endocrinol (Lausanne); 2022; 13():1013238. PubMed ID: 36299451
[TBL] [Abstract][Full Text] [Related]
60. RNA m
Li Y; Sheng H; Ma F; Wu Q; Huang J; Chen Q; Sheng L; Zhu X; Zhu X; Xu M
Cell Death Dis; 2021 May; 12(5):479. PubMed ID: 33980824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
